发明申请
US20120208212A1 METHODS OF ASSESSING CROHN'S DISEASE PATIENT PHENOTYPE BY I2, OMPC AND ASCA SEROLOGIC RESPONSE
审中-公开
通过I2,OMPC和ASCA行为反应来评估冠心病患者的方法
- 专利标题: METHODS OF ASSESSING CROHN'S DISEASE PATIENT PHENOTYPE BY I2, OMPC AND ASCA SEROLOGIC RESPONSE
- 专利标题(中): 通过I2,OMPC和ASCA行为反应来评估冠心病患者的方法
-
申请号: US13312960申请日: 2011-12-06
-
公开(公告)号: US20120208212A1公开(公告)日: 2012-08-16
- 发明人: Stephan R. Targan , Eric A. Vasiliauskas , William S. Mow , Huiying Yang , Phillip R. Fleshner , Jerome I. Rotter
- 申请人: Stephan R. Targan , Eric A. Vasiliauskas , William S. Mow , Huiying Yang , Phillip R. Fleshner , Jerome I. Rotter
- 申请人地址: US CA Los Angeles
- 专利权人: Cedars-Sinai Medical Center
- 当前专利权人: Cedars-Sinai Medical Center
- 当前专利权人地址: US CA Los Angeles
- 主分类号: G01N33/566
- IPC分类号: G01N33/566
摘要:
The invention provides a method of diagnosing or predicting susceptibility to a clinical subtype of Crohn's disease in a subject having Crohn's disease by determining the presence or absence of IgA anti-I2 antibodies in the subject, where the presence of the IgA anti-I2 antibodies indicates that the subject has a clinical subtype of Crohn's disease. In one embodiment, a method of the invention is practiced by further determining the presence or absence in the subject of a NOD2 variant, anti-Saccharomyces cerevisiae antibodies (ASCA), IgA anti-OmpC antibodies, or perinuclear anti-neutrophil cytoplasmic antibodies (pANCA). The methods of the invention can be used to diagnose or predict susceptibility to a clinical subtype of Crohn's disease, for example, a fibrostenotic subtype, a subtype characterized by the need for small bowel surgery, or a subtype characterized by the absence of features of ulcerative colitis.
信息查询
IPC分类: